Start an analysis for ENVA
Enova International, Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $400m | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Remaining authorization | $302m | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Program expiry | 30-Jun-27 | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Repurchased last quarter | $46m | 30-Sep-26 | 10-Q filed 22-Oct-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 12-Nov-25 | $400m | $302m | 30-Jun-27 | On November 12, 2025, the Company announced the Board of Directors authorized a new share repurchase program totaling $400.0 million through June 30, 2027 (the “November 2025 Authorization”), which replaced the prior share repurchase authorization.10-Q filed 22-Oct-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Withheld & other | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|
| 30-Sep-26 | 192,493 | — | $175.48 | $34m | 10-Q filed 22-Oct-26 |
| 31-Aug-26 | 23,872 | 391 | $253.70 | $6m | 10-Q filed 22-Oct-26 |
| 31-Jul-26 | 26,905 | — | $235.77 | $6m | 10-Q filed 22-Oct-26 |
| 30-Jun-26 | 32,683 | — | $186.49 | $6m | 10-Q filed 23-Jul-26 |